DOI:
10.1055/s-00025477
International Archives of Otorhinolaryngology
LinksClose Window
References
Ziepert M, Hasenclever D, Kuhnt E. , et al.
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.
J Clin Oncol 2010;
28 (14) 2373-2380
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.